These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38900824)

  • 1. The role of socio-economic disparities in the relative success and persistence of SARS-CoV-2 variants in New York City in early 2021.
    Vasylyeva TI; Havens JL; Wang JC; Luoma E; Hassler GW; Amin H; Di Lonardo S; Taki F; Omoregie E; Hughes S; Wertheim JO
    PLoS Pathog; 2024 Jun; 20(6):e1012288. PubMed ID: 38900824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Following the Largest Initial Epidemic Wave in the United States: Findings From New York City, 13 May to 21 July 2020.
    Pathela P; Crawley A; Weiss D; Maldin B; Cornell J; Purdin J; Schumacher PK; Marovich S; Li J; Daskalakis D;
    J Infect Dis; 2021 Jul; 224(2):196-206. PubMed ID: 33836067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of housing characteristics in racial and ethnic disparities in SARS-CoV-2 antibody seropositivity among New York City adults: A population representative study.
    Gouse I; Walters S; Miller-Archie S; Singh T; Lim S
    Prev Med; 2022 Nov; 164():107287. PubMed ID: 36208819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent disparities in SARS-CoV-2 test percent positivity by neighborhood in New York City, March 1-July 25, 2020.
    Chan PY; Greene SK; Lim SW; Fine A; Thompson CN
    Ann Epidemiol; 2021 Nov; 63():46-51. PubMed ID: 34391928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.
    Thompson CN; Hughes S; Ngai S; Baumgartner J; Wang JC; McGibbon E; Devinney K; Luoma E; Bertolino D; Hwang C; Kepler K; Del Castillo C; Hopkins M; Lee H; DeVito AK; Rakeman JL; ; Fine AD
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(19):712-716. PubMed ID: 33983915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of SARS-CoV-2 Antibodies in New York City Adults, June-October 2020: A Population-Based Survey.
    Parrott JC; Maleki AN; Vassor VE; Osahan S; Hsin Y; Sanderson M; Fernandez S; Levanon Seligson A; Hughes S; Wu J; DeVito AK; LaVoie SP; Rakeman JL; Gould LH; Alroy KA
    J Infect Dis; 2021 Jul; 224(2):188-195. PubMed ID: 34086923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and "Reopening".
    Jin DK; Nesbitt DJ; Yang J; Chen H; Horowitz J; Jones M; Vandergaast R; Carey T; Reiter S; Russell SJ; Kyratsous C; Hooper A; Hamilton J; Ferreira M; Deng S; Straus D; Baras A; Hillyer CD; Luchsinger LL
    PLoS One; 2021; 16(4):e0250319. PubMed ID: 33909646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Job Function and Work Location in a New York Inner-City Hospital.
    Purswani MU; Bucciarelli J; Tiburcio J; Yagudayev SM; Connell GH; Omidiran AA; Hannaway L; Zeana C; Healy M; Yu G; Reich D
    J Hosp Med; 2021 May; 16(5):282-289. PubMed ID: 33929948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant-specific introduction and dispersal dynamics of SARS-CoV-2 in New York City - from Alpha to Omicron.
    Dellicour S; Hong SL; Hill V; Dimartino D; Marier C; Zappile P; Harkins GW; Lemey P; Baele G; Duerr R; Heguy A
    PLoS Pathog; 2023 Apr; 19(4):e1011348. PubMed ID: 37071654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neighborhood disparities in COVID-19 outcomes in New York city over the first two waves of the outbreak.
    Zhong X; Zhou Z; Li G; Kwizera MH; Muennig P; Chen Q
    Ann Epidemiol; 2022 Jun; 70():45-52. PubMed ID: 35487451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction and Establishment of SARS-CoV-2 Gamma Variant in New York City in Early 2021.
    Vasylyeva TI; Fang CE; Su M; Havens JL; Parker E; Wang JC; Zeller M; Yakovleva A; Hassler GW; Chowdhury MA; Andersen KG; Hughes S; Wertheim JO
    J Infect Dis; 2022 Dec; 226(12):2142-2149. PubMed ID: 35771664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.
    Annavajhala MK; Mohri H; Wang P; Nair M; Zucker JE; Sheng Z; Gomez-Simmonds A; Kelley AL; Tagliavia M; Huang Y; Bedford T; Ho DD; Uhlemann AC
    Nature; 2021 Sep; 597(7878):703-708. PubMed ID: 34428777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 and Inequity: a Comparative Spatial Analysis of New York City and Chicago Hot Spots.
    Maroko AR; Nash D; Pavilonis BT
    J Urban Health; 2020 Aug; 97(4):461-470. PubMed ID: 32691212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.
    Bryan A; Tatem K; Diuguid-Gerber J; Cooke C; Romanoff A; Choudhury N; Scanlon M; Kishore P; Sydney E; Masci J; Bakshi P; Pemmasani S; Davis NJ; Maru D
    BMJ Open; 2021 Nov; 11(11):e053158. PubMed ID: 34732494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatiotemporal Analyses of 2 Co-Circulating SARS-CoV-2 Variants, New York State, USA.
    Russell A; O'Connor C; Lasek-Nesselquist E; Plitnick J; Kelly JP; Lamson DM; St George K
    Emerg Infect Dis; 2022 Mar; 28(3):650-659. PubMed ID: 35133957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module.
    Lee HK; Knabl L; Knabl L; Wieser M; Mur A; Zabernigg A; Schumacher J; Kapferer S; Kaiser N; Furth PA; Hennighausen L
    Sci Rep; 2022 Feb; 12(1):2784. PubMed ID: 35181735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City.
    Duerr R; Dimartino D; Marier C; Zappile P; Wang G; Lighter J; Elbel B; Troxel AB; Heguy A
    J Clin Invest; 2021 Sep; 131(18):. PubMed ID: 34375308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 treatment resource disparities and social disadvantage in New York City.
    Douglas JA; Subica AM
    Prev Med; 2020 Dec; 141():106282. PubMed ID: 33035550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 seroprevalence among health care workers in a New York City hospital: A cross-sectional analysis during the COVID-19 pandemic.
    Venugopal U; Jilani N; Rabah S; Shariff MA; Jawed M; Mendez Batres A; Abubacker M; Menon S; Pillai A; Shabarek N; Kasubhai M; Dimitrov V; Menon V
    Int J Infect Dis; 2021 Jan; 102():63-69. PubMed ID: 33075539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York.
    West AP; Wertheim JO; Wang JC; Vasylyeva TI; Havens JL; Chowdhury MA; Gonzalez E; Fang CE; Di Lonardo SS; Hughes S; Rakeman JL; Lee HH; Barnes CO; Gnanapragasam PNP; Yang Z; Gaebler C; Caskey M; Nussenzweig MC; Keeffe JR; Bjorkman PJ
    Nat Commun; 2021 Aug; 12(1):4886. PubMed ID: 34373458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.